Immunotherapy in Breast Cancer: the New Frontier

Zishuo I. Hu, Heather L. McArthur

Research output: Contribution to journalReview articlepeer-review

20 Scopus citations


Purpose of review: This review summarizes current immunotherapies in breast cancer, with an emphasis on immune checkpoint inhibitors and vaccines. Recent findings: Combination immunotherapy with checkpoint inhibitors and cytotoxic therapies have shown promising results. Active clinical trials are ongoing in both early stage and metastatic settings for triple negative, HER2+, and hormone-positive breast cancer patients. Summary: Ongoing challenges remain in defining biomarkers that predict response to immunotherapy, determining the optimal combination immunotherapies, and enhancing the immunogenicity of breast cancer subtypes.

Original languageEnglish
Pages (from-to)35-40
Number of pages6
JournalCurrent Breast Cancer Reports
Issue number2
StatePublished - Jun 1 2018


  • Breast cancer
  • Checkpoint inhibitors
  • Immunotherapy
  • Vaccines


Dive into the research topics of 'Immunotherapy in Breast Cancer: the New Frontier'. Together they form a unique fingerprint.

Cite this